Literature DB >> 24471053

Importance of immediate surgical intervention and antifungal treatment for rhinocerebral mucormycosis: a case report.

Jin-Geun Kim1, Hye Jeong Park1, Jung Hyun Park1, Jiwoong Baek1, Hyung Jun Kim1, In-Ho Cha1, Woong Nam1.   

Abstract

Rhinocerebral mucormycosis (RCM) is an opportunistic, potentially life-threatening fungal disease. This infective disease invades not only the facial sinuses, but also the maxilla, zygoma, and rhino-cerebral structures with a massive destruction of the facial skeletons and soft tissue. This disease progresses within various underlying diseases, such as diabetes mellitus, hematologic malignancy, renal failure, and systemic immunodepression. The relationship between mucormycosis and these underlying conditions have been discussed extensively in the literature. The authors studied 6 cases of RCM diagnosed by a tissue biopsy and treated at the department of oral and maxillofacial surgery, from 1997 to 2012. Patients were treated with several kinds of surgical interventions and antifungal agents, and their clinical & radiological signs, underlying conditions, surgical methods, and outcomes were analyzed.

Entities:  

Keywords:  Diabetes mellitus; Diagnosis; Mucormycosis

Year:  2013        PMID: 24471053      PMCID: PMC3858134          DOI: 10.5125/jkaoms.2013.39.5.246

Source DB:  PubMed          Journal:  J Korean Assoc Oral Maxillofac Surg        ISSN: 1225-1585


  16 in total

Review 1.  Diabetes and mucormycosis: a complex interplay.

Authors:  B Rammaert; F Lanternier; S Poirée; R Kania; O Lortholary
Journal:  Diabetes Metab       Date:  2012-03-03       Impact factor: 6.041

2.  The surgical management of rhinocerebral mucormycosis.

Authors:  Imad Abu El-Naaj; Y Leiser; A Wolff; M Peled
Journal:  J Craniomaxillofac Surg       Date:  2012-10-09       Impact factor: 2.078

3.  The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus.

Authors:  Arunaloke Chakrabarti; Ashim Das; Jharna Mandal; M R Shivaprakash; Varghese K George; Bansidhar Tarai; Pooja Rao; Naresh Panda; Subhash C Verma; Vinay Sakhuja
Journal:  Med Mycol       Date:  2006-06       Impact factor: 4.076

4.  Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.

Authors:  A H Groll; N Giri; V Petraitis; R Petraitiene; M Candelario; J S Bacher; S C Piscitelli; T J Walsh
Journal:  J Infect Dis       Date:  2000-07-06       Impact factor: 5.226

Review 5.  Mucormycosis in hematologic patients.

Authors:  Livio Pagano; Massimo Offidani; Luana Fianchi; Annamaria Nosari; Anna Candoni; Marco Picardi; Laura Corvatta; Domenico D'Antonio; Corrado Girmenia; Pietro Martino; Albano Del Favero
Journal:  Haematologica       Date:  2004-02       Impact factor: 9.941

Review 6.  Clinical presentation of zygomycosis.

Authors:  E Mantadakis; G Samonis
Journal:  Clin Microbiol Infect       Date:  2009-10       Impact factor: 8.067

7.  Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.

Authors:  Georgios Chamilos; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

8.  Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis.

Authors:  R Y Chinn; R D Diamond
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis.

Authors:  Caitlin Reed; Richard Bryant; Ashraf S Ibrahim; John Edwards; Scott G Filler; Robert Goldberg; Brad Spellberg
Journal:  Clin Infect Dis       Date:  2008-08-01       Impact factor: 9.079

10.  Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006.

Authors:  Dounia Bitar; Dieter Van Cauteren; Fanny Lanternier; Eric Dannaoui; Didier Che; Francoise Dromer; Jean Claude Desenclos; Olivier Lortholary
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more
  3 in total

Review 1.  Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature.

Authors:  Maddalena Chermetz; Margherita Gobbo; Katia Rupel; Giulia Ottaviani; Giancarlo Tirelli; Rossana Bussani; Roberto Luzzati; Roberto Di Lenarda; Matteo Biasotto
Journal:  Mycopathologia       Date:  2016-06-27       Impact factor: 2.574

2.  Rhinocerebral mucormycosis in a diabetic case report.

Authors:  Sm Oladeji; Yb Amusa; Jk Olabanji; Ao Adisa
Journal:  J West Afr Coll Surg       Date:  2013-01

3.  Mucormycosis Management in COVID-19 Era: Is Immediate Surgical Debridement and Reconstruction the Answer?

Authors:  Samarth Gupta; Pradeep Goil; Arbab Mohammad; Joseph M Escandón
Journal:  Arch Plast Surg       Date:  2022-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.